1. Home
  2. KTTA vs MNTSW Comparison

KTTA vs MNTSW Comparison

Compare KTTA & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.69

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Logo Momentus Inc.

MNTSW

Momentus Inc.

HOLD

Current Price

$0.06

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
MNTSW
Founded
2020
N/A
Country
United States
United States
Employees
5
35
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
N/A
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KTTA
MNTSW
Price
$0.69
$0.06
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
351.8K
744.4K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.01
52 Week High
$2.06
$0.13

Technical Indicators

Market Signals
Indicator
KTTA
MNTSW
Relative Strength Index (RSI) 39.23 74.81
Support Level $0.68 $0.01
Resistance Level $0.81 $0.07
Average True Range (ATR) 0.04 0.01
MACD -0.01 0.01
Stochastic Oscillator 9.42 46.83

Price Performance

Historical Comparison
KTTA
MNTSW

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About MNTSW Momentus Inc.

Momentus Inc is a U.S.-based commercial space company engaged in providing satellites, satellite buses, and in-space infrastructure services. The company offers space transportation, hosted payload, and in-orbit servicing solutions, including last-mile satellite delivery, refueling, inspection, maintenance, and debris removal. It also develops satellite technologies such as solar arrays and propulsion systems, and provides production and operation of small satellites for government, defense, and commercial customers.

Share on Social Networks: